68 filings
6-K/A
MOLN
Molecular Partners Ag
17 May 24
Current report (foreign) (amended)
6:25am
6-K
MOLN
Molecular Partners Ag
16 May 24
Current report (foreign)
4:00pm
6-K
MOLN
Molecular Partners Ag
26 Mar 24
Molecular Partners Publishes Invitation to Annual General Meeting 2024
9:34am
20-F
2023 FY
MOLN
Molecular Partners Ag
Annual report (foreign)
14 Mar 24
4:01pm
6-K
MOLN
Molecular Partners Ag
8 Jan 24
Molecular Partners Provides Updates at 42nd Annual J.P. Morgan Healthcare Conference
12:33pm
6-K
4ur8zqswbg4e 0qh5m3
5 Jan 24
Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies
4:00pm
6-K
p33ct42ejsgewjsn2b
11 Dec 23
Current report (foreign)
6:05am
6-K
asc1m jxf1i7pcxy1tr
2 Nov 23
Current report (foreign)
6:01am
6-K
90i2s16
26 Oct 23
Current report (foreign)
4:00pm
6-K
umy5he3v
24 Aug 23
Molecular Partners Reports H1 2023 Corporate Highlights and Financials
4:02pm
S-8
hrhefec
28 Jun 23
Registration of securities for employees
8:34am
6-K
akz7 8a0yqbt19qe
12 May 23
Current report (foreign)
6:05am
6-K
viw3gh 6fd2fnyc771
11 May 23
Current report (foreign)
4:00pm
6-K
jq0e h8ms7jytrlfs
13 Mar 23
Molecular Partners Publishes Invitation to Annual General Meeting 2023
9:30am
6-K
5xou8y2 y3
9 Mar 23
Molecular Partners Reports Corporate Highlights From Q4 2022 and Key Financials for Full Year 2022
4:00pm
6-K
alcbua67p77h60ly sk
17 Jan 23
Current report (foreign)
7:00am
6-K
3yqympammfi45aye7zp
10 Nov 22
Molecular Partners Presents Positive Interim Safety and Mechanistic Data From Ongoing Phase 1 Trial of MP0317 for Treatment of Solid Tumors
8:00am
6-K
875xdnrahe
27 Oct 22
Current report (foreign)
4:01pm
6-K
co9z qd0c8kxd
27 Oct 22
Current report (foreign)
4:00pm